Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness

NCT00203021 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: Glatiramer acetate

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.